DiFi human colorectal cancer cells exhibit unusually high sensitivity to EGFR inhibition: the cells readily undergo apoptosis after treatment with EGFR-blocking monoclonal antibodies or EGFR TKIs [22–27]. Here, EGFR is linked to colorectal cancer.